Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Nan Zheng, PhD

Team Lead
US Food & Drug Administration

Dr. Nan Zheng is a Team Lead at the Division of Cancer Pharmacology I, Office of Clinical Pharmacology (OCP), Office of Translational Sciences, US FDA. Previously she worked as a Scientific Lead for QT and a pharmacometrics reviewer at OCP, and as a science reviewer at the Office of Research and Standards, Office of Generic Drugs, US FDA. Dr. Zheng has extensive experiences in the application of quantitative clinical pharmacology methodologies to support new drug development as well as the bioequivalence evaluation of complex parenteral products or narrow therapeutic index drugs. Dr. Zheng received her Ph.D. in Pharmaceutical Sciences from the University of Michigan.

Disclosure information not submitted.

Presentation(s):